A recent report reveals that Neko Health has successfully raised €60 million ($65.4 million) in venture capital funding.
This funding will enable Neko Health to expand its operations beyond Sweden and into other European countries.
YOU MAY ALSO LIKE: Kentucky Requires Tesla’s Charging Plug In Its EV Companies
Niklas Zennstrom, co-founder of Skype, will join Neko Health’s board as a result of his investment vehicle, Atomico, participating in the funding round.
Neko Health is a medical diagnostics company co-founded by Spotify CEO Daniel Ek.
It specializes in running private clinics equipped with their proprietary diagnostic products, including a full-body 3D scanner.
This advanced technology incorporates multiple sensors that work alongside the company’s artificial intelligence software to provide instant results on potential skin conditions and flag any cardiovascular health concerns.
The company’s first clinic opened in Stockholm earlier this year and has already conducted over 1,000 scans.
Patients visiting Neko Health’s clinics pay €250 for a 10-20 minute full-body exam followed by a review with a doctor.
The demand for their services has been overwhelming, with thousands of individuals currently on the waiting list.
In fact, approximately 80% of clients have pre-paid for follow-up scans within one year.
Hjalmar Nilsonne, the co-founder and CEO of Neko Health, emphasizes that the company employs its own team of nurses, doctors, and specialists to ensure high-quality care for patients.
Dermatologists are specifically hired to review skin images, while an on-site doctor is available to make qualified medical judgments when necessary.
While the COVID-19 pandemic has driven many healthcare startups toward telehealth solutions, Neko Health remains focused on conducting in-clinic testing at this stage.
Nilsonne believes that having medical experts physically present on-site to review and advise client results is essential for providing accurate diagnoses and personalized care.
Given the increased scrutiny of health-tech startups following the Theranos scandal, Nilsonne assures investors that Neko Health operates transparently, setting them apart from the secretive practices of Theranos.
Neko Health is open about its operations and processes. The collaboration between Daniel Ek and Hjalmar Nilsonne began in 2018 when Ek reached out to Nilsonne during Spotify’s IPO.
Both shared a mutual desire to make a positive impact on the world, leading them to explore opportunities in healthcare.
Eventually, they founded Neko Health with the goal of building a healthcare system focused on prevention and patient care.
With the additional investment secured, Neko Health plans to establish clinics in other European countries.
A recent job listing on their website for a doctor in London indicates their expansion ambitions.
Neko Health’s recent funding success marks a significant milestone for the company as it prepares to expand beyond Sweden.
YOU MAY ALSO LIKE: LAC Countries To Benefit Massively From Deep Tech
With its innovative diagnostic products and commitment to transparency and patient care, Neko Health aims to revolutionize the healthcare industry by prioritizing prevention and personalized treatment.
The involvement of prominent investors like Niklas Zennstrom highlights the potential of this medical diagnostics startup to make a lasting impact.
 in venture capital funding.){kind=link}